G. Michael Wall
Keine laufenden Positionen mehr
Profil
G.
Michael Wall worked as a Vice President-Product Development at Otonomy, Inc. before pursuing his education.
He holds a graduate degree from Auburn University and a doctorate from the University of Mississippi.
Ehemalige bekannte Positionen von G. Michael Wall
| Unternehmen | Position | Ende |
|---|---|---|
| OTONOMY | Corporate Officer/Principal | - |
Ausbildung von G. Michael Wall
| University of Mississippi | Doctorate Degree |
| Auburn University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
